Christine A. Pellizzari's Insider Trades & SAST Disclosures
Christine A. Pellizzari's most recent trade in Imunon Inc was a trade of 3,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christine A. Pellizzari.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 3,750 | 3,750 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 4,964 | 23,630 | - | - | Stock Option (Right to Buy) | |
| Tempest Therapeutics Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 4,500 | 18,666 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 4,500 | 14,166 | - | - | Stock Option (Right to Buy) | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Mar 2024 | 37,222 | 0 | - | - | Restricted Stock Units | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Sale or transfer of securities back to the company at price $ 5.75 per share. | 12 Mar 2024 | 35,115 | 0 | - | 5.7 | 201,911 | Common Stock |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | 12 Mar 2024 | 14,579 | 0 | - | 5.7 | 83,829 | Common Stock | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Mar 2024 | 428 | 0 | - | - | Earn-Out Right | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2023 | 355,549 | 1,076,434 | - | 0 | Common Stock | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2023 | 355,549 | 711,097 | - | - | Restricted Stock Units | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. | 12 Aug 2023 | 86,577 | 989,857 | - | 0.4 | 38,094 | Common Stock |
| Tempest Therapeutics Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 16,667 | 726,499 | - | 0 | Common Stock | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 16,667 | 33,333 | - | - | Restricted Stock Units | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 19 May 2023 | 5,614 | 720,885 | - | 0 | Common Stock | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Apr 2023 | 1,270,739 | 0 | - | - | Stock Option | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 702,332 | 709,832 | - | - | Common Stock | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Apr 2023 | 247,000 | 0 | - | - | Stock Option | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal and HR Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Apr 2023 | 238,095 | 0 | - | - | Stock Option | |
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 2,000 | 9,666 | - | - | Stock Option (Right to Buy) | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 17 Nov 2022 | 5,000 | 5,000 | - | 0.8 | 4,032 | Common Stock |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 1,066,646 | 1,066,646 | - | - | Restricted Stock Units | |
| Tempest Therapeutics Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 3,500 | 3,500 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 2,500 | 7,666 | - | - | Option to Purchase Celsion Common Stock | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 50,000 | 50,000 | - | - | Restricted Stock Units | |
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 2,500 | 5,166 | - | - | Option to Purchase Celsion Corporation Common Stock | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 238,095 | 238,095 | - | - | Stock Option | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 1,270,710 | 1,270,710 | - | - | Stock Option | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 247,000 | 247,000 | - | - | Stock Option | |
| Science 37 Holdings Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 8,541 | 8,541 | - | - | Earn-Out Right | |
| Tempest Therapeutics Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 6,635 | 6,635 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Christine A. Pellizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 40,000 | 40,000 | - | - | Option to Purchase Celsion Corporation Common Stock | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.23 per share. | 15 May 2021 | 2,546 | 149,985 (0%) | 0% | 26.2 | 66,782 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 57,200 | 57,200 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 11,810 | 152,531 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 08 Feb 2021 | 15,150 | 155,871 (0%) | 0% | 10.9 | 164,378 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 15,150 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 08 Feb 2021 | 15,150 | 140,721 (0%) | 0% | 45 | 681,750 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 43.95 per share. | 08 Feb 2021 | 6,400 | 140,721 (0%) | 0% | 44.0 | 281,280 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 08 Feb 2021 | 6,400 | 147,121 (0%) | 0% | 10.9 | 69,440 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 6,400 | 15,150 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 25 Jan 2021 | 15,000 | 155,721 (0%) | 0% | 10.9 | 162,750 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 15,000 | 30,150 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 42.95 per share. | 25 Jan 2021 | 15,000 | 140,721 (0%) | 0% | 43.0 | 644,250 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 6,000 | 24,150 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 43.84 per share. | 25 Jan 2021 | 6,000 | 140,721 (0%) | 0% | 43.8 | 263,040 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 25 Jan 2021 | 6,000 | 146,721 (0%) | 0% | 10.9 | 65,100 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 2,600 | 21,550 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 44.04 per share. | 25 Jan 2021 | 2,600 | 140,721 (0%) | 0% | 44.0 | 114,504 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 25 Jan 2021 | 2,600 | 143,321 (0%) | 0% | 10.9 | 28,210 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 10,000 | 45,150 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 20 Jan 2021 | 10,000 | 150,721 (0%) | 0% | 10.9 | 108,500 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 39.87 per share. | 20 Jan 2021 | 10,000 | 140,721 (0%) | 0% | 39.9 | 398,700 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 20 Jan 2021 | 10,000 | 150,721 (0%) | 0% | 10.9 | 108,500 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 41.05 per share. | 20 Jan 2021 | 10,000 | 140,721 (0%) | 0% | 41.1 | 410,500 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 20 Jan 2021 | 10,000 | 150,721 (0%) | 0% | 10.9 | 108,500 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 41.98 per share. | 20 Jan 2021 | 10,000 | 140,721 (0%) | 0% | 42.0 | 419,800 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 10,000 | 65,150 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 10,000 | 55,150 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 45,600 | 45,600 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 9,183 | 140,721 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.29 per share. | 03 Jan 2021 | 1,814 | 132,188 (0%) | 0% | 33.3 | 60,388 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.42 per share. | 03 Jan 2021 | 650 | 131,538 (0%) | 0% | 33.4 | 21,723 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 38,696 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 32.95 per share. | 15 May 2020 | 38,396 | 94,348 (0%) | 0% | 32.9 | 1,265,148 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 38,396 | 132,744 (0%) | 0% | 11.1 | 427,731 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 35,904 | 130,252 (0%) | 0% | 11.1 | 399,971 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 35,904 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 32.32 per share. | 15 May 2020 | 25,000 | 94,348 (0%) | 0% | 32.3 | 808,000 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 25,000 | 39,096 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 25,000 | 119,348 (0%) | 0% | 11.1 | 278,500 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 34.38 per share. | 15 May 2020 | 15,665 | 94,348 (0%) | 0% | 34.4 | 538,563 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.58 per share. | 15 May 2020 | 15,665 | 110,013 (0%) | 0% | 12.6 | 197,066 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 15,665 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 14,351 | 76,413 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 14,351 | 108,699 (0%) | 0% | 11.1 | 159,870 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 15 May 2020 | 14,351 | 94,348 (0%) | 0% | 32.5 | 466,408 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 12,683 | 101,413 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 12,683 | 107,031 (0%) | 0% | 11.1 | 141,289 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 32.34 per share. | 15 May 2020 | 12,683 | 94,348 (0%) | 0% | 32.3 | 410,168 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 34.10 per share. | 15 May 2020 | 12,311 | 94,348 (0%) | 0% | 34.1 | 419,805 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.58 per share. | 15 May 2020 | 12,311 | 106,659 (0%) | 0% | 12.6 | 154,872 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 12,311 | 17,689 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 11,317 | 64,096 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 11,317 | 105,665 (0%) | 0% | 11.1 | 126,071 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 31.87 per share. | 15 May 2020 | 11,317 | 94,348 (0%) | 0% | 31.9 | 360,673 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 10,649 | 90,764 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 10,649 | 104,997 (0%) | 0% | 11.1 | 118,630 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 32.36 per share. | 15 May 2020 | 10,649 | 94,348 (0%) | 0% | 32.4 | 344,602 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 3,750 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.49 per share. | 15 May 2020 | 3,750 | 134,002 (0%) | 0% | 20.5 | 76,838 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 34.55 per share. | 15 May 2020 | 2,024 | 94,348 (0%) | 0% | 34.5 | 69,929 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.58 per share. | 15 May 2020 | 2,024 | 96,372 (0%) | 0% | 12.6 | 25,462 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 2,024 | 15,665 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.46 per share. | 15 May 2020 | 1,575 | 94,348 (0%) | 0% | 25.5 | 40,100 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 1,000 | 75,413 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.14 per share. | 15 May 2020 | 1,000 | 95,348 (0%) | 0% | 11.1 | 11,140 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 32.61 per share. | 15 May 2020 | 1,000 | 94,348 (0%) | 0% | 32.6 | 32,610 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 15 May 2020 | 400 | 94,348 (0%) | 0% | 33.1 | 13,240 | Common Stock |
| Insmed Inc | Christine A. Pellizzari | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 400 | 38,696 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges